 Steven Ojemann
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 22 | 2025 | 153 | 3.790 |
Why?
| | Parkinson Disease | 17 | 2024 | 495 | 2.720 |
Why?
| | Subthalamic Nucleus | 11 | 2024 | 72 | 1.940 |
Why?
| | Drug Resistant Epilepsy | 7 | 2025 | 102 | 1.200 |
Why?
| | Intralaminar Thalamic Nuclei | 2 | 2025 | 16 | 1.000 |
Why?
| | Dystonic Disorders | 2 | 2021 | 25 | 0.910 |
Why?
| | Essential Tremor | 2 | 2021 | 15 | 0.890 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2021 | 46 | 0.710 |
Why?
| | Epilepsy | 4 | 2025 | 334 | 0.520 |
Why?
| | Laser Therapy | 4 | 2021 | 134 | 0.520 |
Why?
| | Stereotaxic Techniques | 3 | 2024 | 40 | 0.470 |
Why?
| | Electrodes, Implanted | 3 | 2020 | 112 | 0.390 |
Why?
| | Globus Pallidus | 3 | 2021 | 26 | 0.350 |
Why?
| | Thalamus | 3 | 2021 | 110 | 0.350 |
Why?
| | Facial Pain | 1 | 2010 | 13 | 0.340 |
Why?
| | Silicones | 1 | 2010 | 25 | 0.340 |
Why?
| | Seizures | 5 | 2025 | 427 | 0.330 |
Why?
| | Vagus Nerve Stimulation | 1 | 2010 | 30 | 0.330 |
Why?
| | Putamen | 2 | 2020 | 23 | 0.310 |
Why?
| | Beta Rhythm | 2 | 2024 | 21 | 0.270 |
Why?
| | Epilepsy, Temporal Lobe | 2 | 2017 | 38 | 0.260 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2005 | 21 | 0.240 |
Why?
| | Electrocorticography | 1 | 2025 | 16 | 0.230 |
Why?
| | Anterior Thalamic Nuclei | 1 | 2024 | 5 | 0.230 |
Why?
| | Amphetamine-Related Disorders | 1 | 2025 | 40 | 0.230 |
Why?
| | Magnetic Resonance Imaging | 10 | 2025 | 3710 | 0.220 |
Why?
| | Methamphetamine | 1 | 2025 | 63 | 0.220 |
Why?
| | Humans | 44 | 2025 | 136898 | 0.220 |
Why?
| | Glutamate Decarboxylase | 2 | 2017 | 170 | 0.220 |
Why?
| | Treatment Outcome | 12 | 2023 | 10768 | 0.210 |
Why?
| | Medical Errors | 1 | 2024 | 110 | 0.210 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 199 | 0.210 |
Why?
| | White Matter | 1 | 2025 | 148 | 0.210 |
Why?
| | Central Nervous System Stimulants | 1 | 2025 | 161 | 0.210 |
Why?
| | Middle Aged | 19 | 2025 | 33118 | 0.210 |
Why?
| | Perioperative Care | 1 | 2025 | 182 | 0.200 |
Why?
| | Brain Mapping | 3 | 2003 | 609 | 0.200 |
Why?
| | Intracranial Aneurysm | 1 | 2023 | 97 | 0.200 |
Why?
| | Genetic Therapy | 2 | 2017 | 295 | 0.190 |
Why?
| | Cerebral Cortex | 2 | 2003 | 459 | 0.190 |
Why?
| | Pars Reticulata | 1 | 2022 | 6 | 0.190 |
Why?
| | Methylphenidate | 1 | 2022 | 38 | 0.190 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 301 | 0.190 |
Why?
| | Psychosurgery | 1 | 2021 | 8 | 0.180 |
Why?
| | Zona Incerta | 1 | 2021 | 3 | 0.180 |
Why?
| | Caudate Nucleus | 1 | 2020 | 23 | 0.170 |
Why?
| | Anticoagulants | 1 | 2005 | 662 | 0.170 |
Why?
| | Meningioma | 2 | 2000 | 90 | 0.170 |
Why?
| | Meningeal Neoplasms | 2 | 2000 | 100 | 0.160 |
Why?
| | Language | 1 | 2003 | 299 | 0.160 |
Why?
| | Health Literacy | 1 | 2022 | 168 | 0.160 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 126 | 0.160 |
Why?
| | Retrospective Studies | 9 | 2025 | 15514 | 0.150 |
Why?
| | Surgery, Computer-Assisted | 2 | 2017 | 99 | 0.150 |
Why?
| | Aged | 12 | 2025 | 23641 | 0.150 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 181 | 0.150 |
Why?
| | Male | 22 | 2025 | 67308 | 0.150 |
Why?
| | Corpus Striatum | 1 | 2020 | 166 | 0.150 |
Why?
| | Psychotic Disorders | 1 | 2020 | 166 | 0.140 |
Why?
| | Female | 20 | 2025 | 72703 | 0.140 |
Why?
| | Radiosurgery | 1 | 2000 | 346 | 0.140 |
Why?
| | Brain | 3 | 2025 | 2828 | 0.130 |
Why?
| | Transcriptome | 1 | 2023 | 973 | 0.130 |
Why?
| | Diffusion Tensor Imaging | 1 | 2017 | 80 | 0.130 |
Why?
| | Postoperative Complications | 3 | 2025 | 2627 | 0.130 |
Why?
| | Vision Disorders | 1 | 2017 | 140 | 0.120 |
Why?
| | Databases, Factual | 1 | 2021 | 1345 | 0.120 |
Why?
| | Amygdala | 1 | 2017 | 208 | 0.120 |
Why?
| | Suicide | 1 | 2023 | 646 | 0.120 |
Why?
| | Adult | 16 | 2025 | 37595 | 0.120 |
Why?
| | Gene Transfer Techniques | 2 | 2017 | 167 | 0.110 |
Why?
| | Depressive Disorder | 1 | 2017 | 383 | 0.100 |
Why?
| | Hippocampus | 1 | 2017 | 903 | 0.090 |
Why?
| | Microelectrodes | 2 | 2024 | 45 | 0.090 |
Why?
| | Motor Cortex | 2 | 2003 | 69 | 0.090 |
Why?
| | Phrenic Nerve | 1 | 2010 | 7 | 0.080 |
Why?
| | Retreatment | 1 | 2010 | 72 | 0.080 |
Why?
| | Speech Disorders | 1 | 2010 | 34 | 0.080 |
Why?
| | Diaphragm | 1 | 2010 | 42 | 0.080 |
Why?
| | Electric Conductivity | 1 | 2010 | 95 | 0.080 |
Why?
| | Quality of Life | 1 | 2022 | 2847 | 0.080 |
Why?
| | Equipment Failure | 1 | 2010 | 107 | 0.080 |
Why?
| | Frontal Lobe | 2 | 2003 | 157 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 21402 | 0.070 |
Why?
| | Young Adult | 4 | 2025 | 13157 | 0.070 |
Why?
| | United States | 2 | 2021 | 14595 | 0.060 |
Why?
| | Electric Stimulation | 3 | 2003 | 272 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5126 | 0.060 |
Why?
| | Hemangiosarcoma | 1 | 2006 | 22 | 0.060 |
Why?
| | Brain Neoplasms | 4 | 2003 | 1227 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2023 | 3528 | 0.060 |
Why?
| | Wakefulness | 2 | 2022 | 129 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2022 | 1063 | 0.060 |
Why?
| | Craniotomy | 1 | 2005 | 78 | 0.060 |
Why?
| | Temporal Lobe | 1 | 2005 | 91 | 0.060 |
Why?
| | Intracranial Hemorrhages | 1 | 2005 | 84 | 0.060 |
Why?
| | Vena Cava Filters | 1 | 2005 | 61 | 0.060 |
Why?
| | Neurons | 2 | 2024 | 1608 | 0.050 |
Why?
| | Accidents, Traffic | 1 | 2005 | 189 | 0.050 |
Why?
| | Circle of Willis | 1 | 2023 | 7 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2023 | 53 | 0.050 |
Why?
| | Intraoperative Care | 1 | 2003 | 49 | 0.050 |
Why?
| | Bone Neoplasms | 1 | 2006 | 250 | 0.050 |
Why?
| | Temporal Arteries | 1 | 2023 | 45 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 56 | 0.050 |
Why?
| | Tremor | 1 | 2023 | 65 | 0.050 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 222 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2022 | 78 | 0.050 |
Why?
| | Hypokinesia | 1 | 2022 | 8 | 0.050 |
Why?
| | Electroencephalography | 1 | 2025 | 436 | 0.050 |
Why?
| | Epilepsy, Complex Partial | 1 | 2001 | 3 | 0.050 |
Why?
| | Epilepsia Partialis Continua | 1 | 2001 | 4 | 0.050 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 2001 | 5 | 0.050 |
Why?
| | Neurocytoma | 1 | 2001 | 1 | 0.050 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2001 | 3 | 0.050 |
Why?
| | Hemiplegia | 1 | 2001 | 21 | 0.050 |
Why?
| | Substantia Nigra | 1 | 2022 | 57 | 0.050 |
Why?
| | Dominance, Cerebral | 1 | 2001 | 56 | 0.050 |
Why?
| | Upper Extremity | 1 | 2022 | 100 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2021 | 70 | 0.040 |
Why?
| | Neural Pathways | 2 | 2020 | 318 | 0.040 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2001 | 66 | 0.040 |
Why?
| | Preoperative Care | 1 | 2003 | 356 | 0.040 |
Why?
| | Action Potentials | 1 | 2024 | 502 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 109 | 0.040 |
Why?
| | Internal Capsule | 1 | 1999 | 2 | 0.040 |
Why?
| | Supratentorial Neoplasms | 1 | 1999 | 17 | 0.040 |
Why?
| | Atrophy | 1 | 2020 | 184 | 0.040 |
Why?
| | Monitoring, Intraoperative | 1 | 1999 | 56 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 765 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2017 | 1980 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2000 | 690 | 0.040 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1999 | 148 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1684 | 0.030 |
Why?
| | Parvovirinae | 1 | 2017 | 3 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 2 | 2005 | 2670 | 0.030 |
Why?
| | Electromyography | 1 | 1999 | 400 | 0.030 |
Why?
| | Visual Pathways | 1 | 2017 | 56 | 0.030 |
Why?
| | Visual Fields | 1 | 2017 | 90 | 0.030 |
Why?
| | Dependovirus | 1 | 2017 | 69 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 779 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1972 | 0.030 |
Why?
| | Life Change Events | 1 | 2017 | 153 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 299 | 0.030 |
Why?
| | Visual Cortex | 1 | 1995 | 73 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 1039 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2000 | 1057 | 0.030 |
Why?
| | Biomarkers | 1 | 2025 | 4148 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3282 | 0.030 |
Why?
| | Aging | 1 | 2003 | 1863 | 0.020 |
Why?
| | Palliative Care | 1 | 2017 | 737 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10313 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6802 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2744 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7543 | 0.020 |
Why?
| | Ifosfamide | 1 | 2006 | 37 | 0.020 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2006 | 4 | 0.020 |
Why?
| | Hemorrhagic Disorders | 1 | 2006 | 10 | 0.020 |
Why?
| | Laminectomy | 1 | 2006 | 31 | 0.020 |
Why?
| | Hemostasis | 1 | 2006 | 82 | 0.020 |
Why?
| | Child | 2 | 2003 | 21896 | 0.020 |
Why?
| | Sacrum | 1 | 2006 | 80 | 0.010 |
Why?
| | Doxorubicin | 1 | 2006 | 363 | 0.010 |
Why?
| | Embolization, Therapeutic | 1 | 2006 | 227 | 0.010 |
Why?
| | Blood Transfusion | 1 | 2006 | 324 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2006 | 1240 | 0.010 |
Why?
| | Magnetoencephalography | 1 | 2003 | 147 | 0.010 |
Why?
| | Speech | 1 | 2003 | 77 | 0.010 |
Why?
| | Functional Laterality | 1 | 2003 | 229 | 0.010 |
Why?
| | Cerebral Ventricles | 1 | 2001 | 52 | 0.010 |
Why?
| | Electrocoagulation | 1 | 2001 | 40 | 0.010 |
Why?
| | Aneurysm, Ruptured | 1 | 2001 | 35 | 0.010 |
Why?
| | Cerebral Angiography | 1 | 2001 | 109 | 0.010 |
Why?
| | Animals | 1 | 2022 | 36914 | 0.010 |
Why?
| | Glioma | 1 | 2003 | 385 | 0.010 |
Why?
| | Hand | 1 | 1999 | 160 | 0.010 |
Why?
| | Isometric Contraction | 1 | 1999 | 188 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1689 | 0.010 |
Why?
| | Planning Techniques | 1 | 1995 | 16 | 0.010 |
Why?
| | Child, Preschool | 2 | 2001 | 11013 | 0.010 |
Why?
| | Tomography, Emission-Computed | 1 | 1995 | 71 | 0.010 |
Why?
| | Neurosurgery | 1 | 1995 | 39 | 0.010 |
Why?
| | Astrocytoma | 1 | 1995 | 128 | 0.010 |
Why?
| | Photic Stimulation | 1 | 1995 | 254 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 1999 | 1699 | 0.000 |
Why?
| | Infant | 1 | 1999 | 9408 | 0.000 |
Why?
|
|
Ojemann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|